✦ LIBER ✦

Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review

✍ Scribed by M.R Tramèr; D.J.M Reynolds; N.S Stoner; R.A Moore; H.J McQuay

Book ID: 117665876
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 98 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)00161-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-HT3Receptor Antagonists for the Preven

5-HT3Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting

✍ R. Elizabeth Gregory, Professor David S. Ettinger 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 314 KB

Timing and duration of 5-HT3receptor ant

Timing and duration of 5-HT3receptor antagonist therapy for the prophylaxis of radiotherapy-induced nausea and vomiting: a systematic review of randomized and non-randomized studies

✍ Kristopher Dennis, Leila Makhani, Ernesto Maranzano… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 213 KB

Clinical Science Review: Comparative Rev

Clinical Science Review: Comparative Review of 5-HT 3 Receptor Antagonists in the Treatment of Acute Chemotherapy-Induced Nausea and Vomiting

✍ Hesketh, Paul J. 📂 Article 📅 2000 🏛 Informa plc 🌐 English ⚖ 960 KB

Impact of 5-HT3receptor antagonists on c

Impact of 5-HT3receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study

✍ Swu-Jane Lin, Hind T Hatoum, Deborah Buchner, David Cox, Sanjeev Balu 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 178 KB

Prophylaxis of Radiation-Induced Nausea

Prophylaxis of Radiation-Induced Nausea and Vomiting Using 5-Hydroxytryptamine-3 Serotonin Receptor Antagonists: A Systematic Review of Randomized Trials

✍ Nadia Salvo; Brett Doble; Luluel Khan; Gayathri Amirthevasar; Kristopher Dennis; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

GR38032F, a 5HT3receptor antagonist, in

GR38032F, a 5HT3receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting

✍ Michel Marty; Jean P. Droz; Pierre Pouillart; Bernard Paule; Nils Brion; Jacques 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 330 KB

A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/ m 2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor antagonist, was given 30 min prior to cisplatin as